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ankles was apparent and stood in contrast to higher magnitude 
and more focal exposures in the incongruous joints. 
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cumulative contact stress exposure per annum (MPa). 
Fractured ankles also exhibited correspondingly smaller area per- 
centages exposed to lower stresses. 
Conclusions: The present ankle cartilage stress data represent 
among the first successful applications of intra-articular contact 
FE analysis to a clinical series, on a patient-specific basis. Re- 
spective normal ankle instantaneous contact stress distributions 
at similar instants of the duty cycle, as well as cumulative whole- 
cycle contact stress exposures, showed expected individual vari- 
ations on common general patterns. Although preliminary in na- 
ture, the contact stress data from the normal ankles as a group 
differed appreciably from the situation prevailing for residual frac- 
ture incongruity. 
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Aim of Study: Previous studies in our laboratory have demon- 
strated increases in glycosaminoglycans (GAG), proteoglycans 
(PG) and TGFI~ in articular cartilage and a delay of osteoarthri- 
tis (OA) progression in Hartley guinea pigs with exposure to cer- 
tain pulsed electromagnetic fields (PEMF). This study examines 
the effect of treatment with a specific PEMF upon PG synthesis, 
GAG content, and mechanical properties of human OA cartilage 
explants. 
Methods: 3mm human chondral cores were harvested from the 
lateral femoral condyle, lateral tibial plateau, and trochlea of 7 pa- 
tients undergoing total knee arthroplasty for treatment of OA with 
varus deformity. Mankin scoring was utilized to grade the histolog- 
ical severity of OA in each donor site. The chondral cores were 
cultured in DMEM and exposed to a specific PEMF for 1 h/day or 
4h/day for 14 days. Control groups were treated identically, but 
without PEMF exposure. [35S]-Sulfate incorporation, DNA quan- 
tification, and GAG content were deteremined by standard meth- 
ods. The aggregate modulus was determined with a confined 
compression test. 
Results: 1h/day PEMF treatment increased [35S]-Sulfate incor- 
poration in chondral cores harvested from the lateral femoral 
condyle and trochlea by 15.6% (p=0.0175) and 16.1% (p=0.0837) 
respectively when compared to control. No effect was observed 
in the lateral tibial plateau. 4h/day PEMF treatment decreased 
[35S]-Sulfate incorporation in lateral femoral condyle and tibial 
plateau by 10.5% (p=0.0354) and 17.15% (p=0.0329) respec- 
tively. No effect was observed in the trochlea. Stratification of 
the data by Mankin score demonstrated that chondral cores har- 
vested from sites with more severe OA (Mankin score > 6) re- 
sponded poorly to PEMF treatment. The tibial plateaus used in 
this study had Mankin scores > 6 suggesting that the lack of re- 
sponse in the 1 h/day treatment group was due to severity of OA 
rather than site specifity. GAG content increased by 35% (p=0.04) 
with 1h/day PEMF treatment. Aggregate modulus values were 
approximately 15% higher in the PEMF treated group. 
Conclusions: Stimulation of extracellular matrix (ECM) 
molecules can be achieved with certain configurations of dy- 
namic mechanical stress. Mechanical loads stimulate a number 
of strain-associated events, notably streaming potentials, which 
may act as secondary signaling phenomena. Electric currents 
can be induced in cartilage by externally applied electromagnetic 
fields without mechanical strain. Our data indicates that these 
fields induce a reconstitution of PG and GAG in human OA carti- 
lage together with an increase in aggregate modulus and there- 
fore can be said to be mechanomimetic. This occurs only in OA 
of mild severity and is related to exposure duration, frequency, 
and amplitude of the field. These results suggest a potential ther- 
apeutic application for this specific PEMF in the treatment of early 
OA. 
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Aim of Study: Glucosamine pharmacokinetics has been recently 
described in humans after administration of the original crys- 
talline glucosamine sulfate preparation at therapeutic doses. This 
was possible thanks to the development and validation of an 
LC/MS/MS method with adequate sensitivity and specificity. Pre- 
vious animal studies with less sensitive methods and different 
glucosamine substances have suggested glucosamine absolute 
bioavailability to range between 6% and 21% The aim of the 
present study was to assess the absolute bioavailability of glu- 
cosamine after administration of crystalline glucosamine sulfate 
in the rat at pharmacologically relevant doses. 
Methods: Male Sprague-Dawley rats were treated with crys- 
talline glucosamine sulfate at the doses of 200 mg/kg by the oral 
and intravenous routes. This dose is similar to the human thera- 
peutic dose in osteoarthritis (1500 mg/day) as it corresponds to a 
human equivalent dose of 2000 mg for a 65 kg man. Plasma was 
collected before oral and intravenous administration and up to 
48 h from cannulated animals. Glucosamine plasma concentra- 
tions were determined by LC/MS/MS after extraction with trichloro 
acetic acid with a limit of quantitation of 2 ng/ml. 13C-labelled glu- 
cosamine was used as internal standard. The plasma concentra- 
tions were used for a non-compartmental pharmacokinetic anal- 
ysis. 
Results: The table below shows the results obtained. After oral 
administration of crystalline glucosamine sulfate at the dose of 
200 mg/kg, glucosamine is rapidly absorbed (Tmax = 0.25 h) 
and is available to the systemic circulation in rats. The absolute 
bioavailability is approximately 27%. After both oral and intra- 
venous administration unchanged glucosamine was detected in 
Mean (SD) pharmacokinetic parameters of glucosamine after oral and 
intravenous administration of crystalline glucosamine sulfate at the dose of 
200 mg/kg (n=3 for each administration route) 
Administration Route 
Parameter Oral Intravenous 
Cmax (ng/ml) 1057.8±771.5 2108.9±28.5 
AUCt (ng.h/ml) 1034.2±172.6 3957.7±589.3 
F (%) 26.6 - 
